KIMS:NSE-Krishna Institute of Medical Sciences Limited (INR)

COMMON STOCK | Medical Care Facilities | NSE

Last Closing Price

INR 1,360.05

Change

0.00 (0.00)%

Market Cap

INR 108.81B

Volume

0.21M

Avg Analyst Target

INR 1,611.29 (+18.47%)

Avg User Target

INR
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


KIMS Stock Forecast & Price:
Based on the Krishna Institute of Medical Sciences Limited stock forecasts from 4 analysts, the average analyst target price for Krishna Institute of Medical Sciences Limited is INR 1,611.29 over the next 12 months. Krishna Institute of Medical Sciences Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Krishna Institute of Medical Sciences Limited is Bullish , which is based on 7 positive signals and 3 negative signals. At the last closing, Krishna Institute of Medical Sciences Limited’s stock price was INR 1,360.05. Krishna Institute of Medical Sciences Limited’s stock price has changed by +11.18% over the past week, +12.20% over the past month and 0% over the last year.

About Krishna Institute of Medical Sciences Limited (KIMS:NSE)

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-09-25 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
APOLLOHOSP:NSE Apollo Hospitals Enterprise Li..

N/A

INR635.31B 71.91 31.92
MAXHEALTH:NSE Max Healthcare Institute Limit..

N/A

INR413.86B 67.24 39.07
FORTIS:NSE Fortis Healthcare Limited

N/A

INR198.03B 48.48 18.77
NH:NSE Narayana Hrudayalaya Ltd.

N/A

INR143.22B 37.82 19.76
ASTERDM:NSE Aster DM Healthcare Limited

N/A

INR119.23B 22.94 10.73
RAINBOW:NSE Rainbow Childrens Medicare Lim..

N/A

INR63.71B 49.96 22.71
HCG:NSE Healthcare Global Enterprises ..

N/A

INR38.97B 55.84 13.49
MAXINDIA:NSE Max Healthcare Institute Limit..

N/A

INR18.42B 5.20 N/A
SHALBY:NSE Shalby Limited

N/A

INR14.72B 21.41 12.01
INDRAMEDCO:NSE Indraprastha Medical Corporati..

N/A

INR6.14B 9.73 4.62

ETFs Containing KIMS

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.60% 40% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.60% 40% F 46% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 108.81B 58% F 83% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 31.33 64% D 35% F
Price/Book Ratio 7.85 33% F 14% F
Price / Cash Flow Ratio 33.58 36% F 22% F
EV/EBITDA 20.44 42% F 26% F
Management Effectiveness  
Return on Equity 30.07% 100% A+ 91% A-
Return on Invested Capital 24.61% 100% A+ 91% A-
Return on Assets 16.72% 100% A+ 96% A
Debt to Equity Ratio 9.92% 89% B+ 54% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.